Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Reply 113171 SPORT. I'm regular haha. Haven't missed a week in years. It's been a difficult slog, but as I used to post, we're closer to the end than when this started. Could not have made up the way this unfolded. That just gets me thinking that ISRG is doing what it can behind the scenes to keep this from happening. I think MDT was hoping their design would work out, but it didn't and now they've pushed the "easy" button. If the MDT CEO is a buyout guy, then there's draft board of possibilities, and plan B's as those targets move through their own progression. Unless someone else can provide more insight as to other robotic surgery options then TMDI is the closest by far. Would not want to be a competitor without an option for robotic surgery for the next 10 year strategic plan. Here we are. Regards, BK.
You back? Good to hear from you. Till next time. Regards,BK
Response SPORT 113156
You keep conveniently forgetting that JNJ and MDT delayed their present builds for at least another 2 years. Time's money, and MDT licensed TMDI's IP because they don't have the time and it's cheaper to buy established IP. It just is. Especially with a workable design. Design, development, testing, proof of concept, redesign. BIG$$$$. MDT, and anyone else that can get some of TMDI's IP will pay because they can't get to market soon enough. Time is money, and 10-20 year competitive advantage is not just walking around to easily capture. Big deal so Mc licensed some IP for $10M. What are the terms of that agreement? TMDI still owns the IP. MDT can choose with whomever they wish to partner, and buy anything. So can the other large Med-tech co's. Perspective. If it were easy to build there would be at least 4 or 5 of these things working. But.....there isn't. I hear your arguments. What I don't hear from you is that there's a better solution from another company for Single-Port. Nothing else out there, or you wouldn't be here either. I'll still drink with you and the group someday, but really this narrative you keep using to try and get traction doesn't make sense going forward..... Regards,BK.
They did repost at Stockhouse and at CEO.CA. There's serious reluctance because Roger over spoke about projections. 10M was a big reach for the laser division revenue. But I can't fault him for his vision to license the PDT IP. That said, I think perhaps Dr. McFarland is a little frustrated with the lack of progress. I live in north TX, and actually could try to reach her at UT Arlington if this bug would ever go away. I would be an absolute honor to meet her. Someday.
Regards,
BK
Great post. Been here since 2014 too. The science is everything from my analysis. It would be so beneficial if management would comment on the Roswell Park events. It could open a new line of communication and enthusiasm from the longs, and change all of the perception about the company at this time. It's easy to be happy when things are going well. It's a testament to management skill navigating rough water. This could be a great opportunity to showcase the fixes, as much as admit the mistakes. Thank you. BigKahuna.
This may have been mentioned, but I don't recall. What if - TMDI negotiated the current agreement for the IP for only HUGO? Of course the ownership of any IP developed going forward is owned by MTD, but I don't recall hearing that the IP was applicable to any product. Did we get the entire agreement for review? Just asking - trying to be completely objective, b/c that would lend some credibility to the possibility of expanded licensing agreements with other Mfr's. IMO I don't think MDT would let that get out of their control, but again I don't recall all of the agreement details. Any thoughts from the board as to whether the IP was product specific?
Ok, that sounds bad, and sucks for him. But everyone knew Titan needed funds. Why leave MDT to go to TMDI? TMDI wasn't ready for commercialization, and not close to CE or FDA. Something seriously doesn't add up. Why leave MDT to go to TMDI? Your information may be correct, but something else is missing. It doesn't fit. But, thank you for the follow up.
I think what you say is true. But why would the technology be tied up and secured by the $1.5M loan (which can be increased - see below), when TMDI can pay it off now? And the terms for repayment are years down the road?
To support development, Titan has received a senior secured loan of U.S. $1.5 million from Medtronic which was announced on April 29, 2020. The loan, which will be increased by an amount equal to certain legal, transaction and intellectual property related expenses pursuant to the definitive agreements, will be evidenced by an amended and restated promissory note, and will bear interest at the rate of 8% per annum. The loan is repayable on June 4, 2023, or upon the earlier completion of the last milestone under the development and license agreement or a Change of Control of Titan (as defined in the note). Until repayment of the loan, Medtronic may have one non-voting observer attend meetings of Titan’s Board of Directors. The loan will be secured by way of a security agreement entered into by Titan and pursuant to which Titan has granted a security interest in favor of Medtronic in all of Titan’s present and future property including all personal property, inventory, equipment and intellectual property. Those are weird terms, unless MDT is going to secure the IP. Again I ask, why would MDT "let" anyone else get this IP. It's THE barrier to entry into the marketplace going forward for the next 10-15 years. IMO.
I don't understand your point. I don't care if, or how he gets paid by TMDI. Someone had to be inside to get firsthand knowledge of TMDI's status, pre FDA. He can still have a consulting agreement with MDT at the same time......so long as it's disclosed to TMDI.
Reply JNJ/Medronic/TMDI together.
Interesting theory, but I go back to why would MDT go for sharing anything with JNJ, instead of buying TMDI outright? And, how could JNJ participate if ALL of the ip being developed going forward belongs to MDT? Life & Death on the corporate battlefield is about owning IP. It's THE detail of owning of ALL technology developed with TMDI, going forward that precludes me from believing another company will buy TMDI. However, it doesn't stop another company from owning shares of TMDI and making the buyout very difficult (aka expensive). IMO.
5Under Post 112406 Reply
MDT does not have an approved robot for general surgery, non competes don’t cover things that are not approved. Zaring did not violate his non compete when he went to Titan.
Non competes can cover ANY proprietary and/or confidential company information. Like an acquisition business plan? He was given permission to go. But why? I question the thought about getting hired to go raise money, and then he left. That implies TMDI hired him to raise money and he agreed, or they didn't tell him and hired him under false pretenses? Not likely. Clearly TMDI knew they weren't ready for commercialization, and so did he. They aren't near FDA approval, and they needed financing. Zaring either went there b/c MDT sent him there. Or.. he just lucked into some "unnamed job" at TMDI that holds the best cutting-edge IP for robotic surgery? He didn't leave MDT just because he was bored. He's the bird dog for MDT (IMO).
MX77 - Post 112347 Reply
I agree completely about the Zaring non-compete issue while working at MDT. That was a loose end that gnawed on me for a long time. When I see so many circumstances, and try to connect the dots - it always comes back to "what's the motivation?" The WIFM "what's in it for me?"
And I bought a little more yesterday. The only way to salvage my investment is to average down. I hope others have that option.
I think this is just drifting (because of manipulation) until there's solid news. I've posted for years, and my estimates have been dead wrong. I do believe there will be a very positive outcome, but don't know when. I believe in the IP, and the thought that MDT is involved. I think there are many reasons for delays. Too many "good ideas," ISRG's expiring IP, and an over abundance of caution competing against the 800# gorilla. I also think that investment $$$'s have been scarce b/c of the 800# gorilla. What ever else I think doesn't matter. My best to everyone. BK.
MX77 - Post 112347 Reply
I agree completely about the Zaring non-compete issue while working at MDT. That was a loose end that gnawed on me for a long time. When I see so many circumstances, and try to connect the dots - it always comes back to "what's the motivation?" The WIFM "what's in it for me?"
And I bought a little more yesterday. The only way to salvage my investment is to average down. I hope others have that option.
I think this is just drifting (because of manipulation) until there's solid news. I've posted for years, and my estimates have been dead wrong. I do believe there will be a very positive outcome, but don't know when. I believe in the IP, and the thought that MDT is involved. I think there are many reasons for delays. Too many "good ideas," ISRG's expiring IP, and an over abundance of caution competing against the 800# gorilla. I also think that investment $$$'s have been scarce b/c of the 800# gorilla. What ever else I think doesn't matter. My best to everyone. BK.
Reply to Post 110682 You see this and the rest of the market doesn't OR do they know better - Someone has to pay to play. Even if costs go up $100M, someone is still going to pay to develop their own bot, or pay to license TMDI patents. The cost is the same for everyone, except THE company that licenses the IP that exists. That company will save money by shortening the time to develop and patent the tech necessary to participate in the robo surgery market. Time is money. The JNJ timeline will be an element going forward, unless MDT really tied up Titan. I'll guess MDT already planned for JNJ and others getting desperate. Point 2 - Your point that we're at $.85, or where ever is valid, but everyone knows that the share price is being "m-a-n-i-p-u-l-a-t-e-d." ISRG is not going to just open the door and say "welcome." And any of our competitors will try to slow down progress. Competition can't slow down development, except by cutting off the flow of funds necessary to finish development. But MDT as a suitor has changed that scenario.
Why would patients "need" to go into hospitals? Why not Ambulatory Surgery Centers? They're smaller, and easier to manage. Just a thought. Also, in response to Mongo, should there be a bidding issue, MDT would only need to get an agreement with Titan for a right of first refusal to maintain the lead.
Response to "Huge for Titan or ISRG?"
I have to make this message a little different from earlier today. Regardless. With all of the options in the universe, I keep coming back to the fact that Medtronic has billions at its disposal for critical future investment growth and can spend it anywhere they wish. They spent it with Titan. Why? No one knows except Medtronic and Titan. But we do know previously 63 times they did their DD before they spend money. This is not a hollow endeavor. It's not a head fake. They have to decide how to grow the business for the next 10-20 years. Things that make you go Hmm........ Good luck and best wishes to all. I wish Lefty, Daktari, CUIN2, and a few others would pop in from time to time.
I'm still in. Will buy more soon, but cautious. I loved this tech and the IP years ago, and it's just continued to get better, with more good news. But the pps hasn't moved b/c of funding. I'm convinced that there's more than 1 major buyer looking over this opportunity. There's too much riding on the future and it's too difficult to recreate this type of technology. The most important move was made a year ago this past January when Mc had the IP reviewed by the patent attorney's that do ISRG's IP too. When that came back clean, or supposedly clean this should have taken off. I've made too many assumptions - all incorrect. Who knew? Hi...... I'm Bigkahuna57 and I'm a SPORT addict. Best to all.
Regards,
BK
Hi CUIN2,
Got your messages. Looking into it. Many thanks for thinking of me.
Regards,
BK
Hi EIT. I don't know whether these mod's are absolutely necessary. If they aren't then I'd have serious emotions because this is supposed to be able to perform surgical procedures to benefit the patient and enhance the surgeon's ability to perform them. And up until this point - I've taken our friends of this board's understanding that this device works as necessary. Anything other than "absolutely necessary," and I would be asking Mc why. Now I can see one option as, perhaps some of the points that the current sites are making can be done at the same time as a perfectly necessary issue. Of course that "fix" or enhancement expense better be way beyond a nice feature to justify the expense. And again, I agree with many here regarding the dilution and time to market. I fix my car, and do the research to see if there's another big expense coming down the road, to have it done at the same time.
My logic and BS meter doesn't go off because I don't see the purpose behind unnecessary delays. FOR ANY REASON. This last announcement would be the LAST thing I'd want to do. Mc & Mr. Genova would have had to conclude "while we have the lid off of this thing for a little more money, and no more extended time line - we should do X." Yes the disparate components are an issue for production and diagnostics (for pre-surgery and for device field repair).
I think the "why do this now," is the source of much of our group anxiety.
I don't know what else to conclude without the facts.
Regards,
BK
Hello to all. Been reading most everyday. Just a few comments for all to consider. First - this is not extremely expensive as compared to the existing device and the IP that ISRG holds. Our IP is more valuable based on the articulation of the moving parts, docking station, surgeon control and interface. JMO. Further, with regard to the consolidation of processors and ic boards - with so many different sub-assemblies being produced, the Chief Engineer would know that to move to production, the controllers and circuit boards would need to be consolidated for ease of maintenance, and it's standard practice from moving from wire wrapped boards to controller mother boards. And.. management of the software on multiple operating systems. It's not easy managing devices integrated from different software languages, and operating systems. My point is that as an engineer with any digital device development, that has launched a product into production, would have noticed that right away. It's the equivalent to having a home inspected prior to buying it.
And Mc did his due diligence as the CEO too. If I remember correctly (please correct me if I recall incorrectly) - He had the IP reviewed at the same patent attorney office as ISRG. The best way to keep from going to battle is to have your enemy know they couldn't win the war before it starts. Again, JMO.
This is not a manipulative delay. This is a standard process to get to production from design, development, to testing, to field prototype. The only reason someone else hasn't launched a competitive product yet is because of the IP, possessed by ISRG and their deep pockets. Clearly we have the surgeons best interest with this design. ISRG wanted a surgical robot. We want a surgical robot that extends the useful life and expertise of the surgeon.
Lastly, if anyone was going to invest in this company with millions of dollars, the first place to look is the IP. Someone with a lot more money than I, knows this is a calculated risk, but not a gamble.
Good luck my friends. Aberlour A'bunadh anyone?
Regards,
BK
I agree with you. There's no reason to invest what funding we have secured for a feature that isn't necessary to launch SPORT.
It would benefit the pps if Verb did mention working with Titan, but will they provide the details that would contribute to a better understanding of how we sell more SPORTS?
Let's not lose site of the fact that one of the single best benefits of SPORT is to extend the useful life of a surgeon, which would otherwise need to retire with decades of experience. This is truly an significant reason to own SPORT.
JMO - We should move in a straight line to certifications. Verb will move as fast as they need to with or without SPORT. If it's with SPORT - great, but it's not worth causing a delay for their platform.
Regards,
BK
I'd like to think that you're correct. I just don't have a clue what can be shared. Now with regard to the company itself, yes we should be getting some form of update. But I'm hedging when I say - if those updates are material to the trials or plans for trials, we don't know how that information is germane to the what activity is taking place at PMH. We know the company has little revenue from the pain management side, but is supposedly working on upgrading and expanding the customer base. I don't think revenue or updates about that side of the company moves the pps much.
You and I will know more when the volume starts increasing without updates.
GLTU
Regards,
BK
Hi la,
I'm using the company web site, annual statements, and mostly the PR's, and announcements. Also the PP's and value of the amounts raised, based on the business plans that have been shared by the company itself. The recent announcement of the Green Tree purchase. I also take into consideration the movement of the company, such as the partial sale of NVL to EMH, and the hiring of the individual that licensed the raybot technology. Business inroads connected with China. All are listed and available on the home page of this site. My investment in the mj sector has always been more into the lab, oil, edibles/drinkables segment. Anyone and everyone has a grow license. For me it's the science of the IP that drives my interest.
GLTU
Regards,
BK
I don't post much here, but read daily. Thank you to those that have contributed the majority of the DD, and industry/local business information. I think you'll see more up. Time doesn't stop for traders, and we're seeing consolidation, and further business development. My point is that we could get to +$1 in a blink, and possibly $2 based on the ability to invest in a publicly traded company in this sector that's undervalued compared to it's peers. The question is - will those that have been investing since these new developments have come to the public's attention get in now or wait further and pay more. This company is positioned really nicely for its capabilities and it's future value. Canada will not stop this train, it needs the tax revenue. That's what will ultimately cause the states to do the same. I for one, am glad there's so much controversy over rec. and med in the states, so the opportunity consolidates in Canada for at lease this year. The company is not going away, it's only going to get more expensive to invest. The question is when will others jump in. JMO.
Regards,
BK
Hi Cuin,
I'm still here, and I agree with you, but isn't he bound by the communication permitted through PMH?
Have a good one.
BK
JMO - I'm getting excited again. We're very close. SPORT will have so many new customers from which to choose. The ISRG SP model won't meet the functional equivalent of SPORT's overall list of indications. Based on what I've read and recall from past posts. Titan will have a backlog of pre-orders well beyond their capability to manufacture as soon as FDA approval is announced. There's a high probability that a large partner will not hold off from getting in based on the competitive environment.
Wondering out loud - I'l love to hear the conversation about our IP from which SPORT 1.2.3 and the future of SPORT "anemone." The IP is compelling. What's to keep Titan from making the existing arms at the wrists and making smaller "fingers" with 2 miniature end effectors? Once the surgical field is established and the 3 dimensional zones established, then the arms and fingers will coordinate. Changing end effectors won't need to be redesigned, just adjusted for further travel from the tips of the fingers. Or possibly not at all - what if the end effectors are already attached and SPORT just changes our the fingers? Clearly this is an over-simplification, but doable from an engineering point of view. Again, it's our IP, based on the flexibility and reach capabilities from within the existing patents.
ISRG will have their own issues managing the existing customer base and selling to new customers that either didn't want the existing model, or didn't want to do business with ISRG - for what ever reason.
It's Titan's race to get to the first 10, 100, 500 and 1,000 units.
The new Dr reviews, PR's and videos will have a big effect on those that are aware and those that are just about to pull the trigger. The question is how much of an effect will they have on the pps, and whether investors want to get in sub $, or wait because they have so much money $1-$2 pps doesn't matter.
Strategically, I'd think that Mc showed videos in those +30 meetings this week. I think the public release of the videos and additional Dr. driven buying groups will be the triggers. I wouldn't wait to release them.
Again, jmo.
GLTA
Regards,
BK
Thank you Flenderson. I always look forward to reading your posts. Everyone have a calm and relaxing weekend.
Regards,
BK
JMO - For all of the gnashing of teeth and wringing of hands lately in many posts, I hold to the thoughts that there's more to this than I will ever know. Meaning that the past several PP's for millions of $$$ would not have taken place if this company didn't have a meaningful business plan. And that plan was far enough along to generate the interest. While this investment has risks, I saw further justification from those PP's to be happy that I'm in. I've been long for a very long time and I think we're very close to seeing many great increases in the share price. I'm in it for the $$$.
GLTA
Regards,
BK
FYI - v Stockhouse user Bogdansz
Fear not !!!
http://www.baystreet.ca/stockstowatch/2878/Looming-Legalization-has-Cannabis-Producers-Thinking-Outside-the-Dispensary
Regards,
BK
We are happy to have you join us and add you to the list of those that do not hold the same opinion in spite of the current progress of the company. Please be sure to include the milestones that have been achieved and those scheduled for the near future, that those outstanding shares have funded. We like to give credit and show our appreciation to those that try to make a point by presenting all of the relevant information with their supporting argument(s).
I'm of the opinion that the medical professional community is so large that you will garner support for the product that you profess to be superior to SPORT. I just think you're wasting your time posting here as SPORT is already more functional and more popular pre-FDA approval.
Regards,
BK
Please bestow upon us your wisdom as to how you would finance the further development of SPORT? Clearly you are aware of more than those of us that are happy with the successful conclusion of many previous milestones, and the financing of those that are scheduled in the near future. We request substance to further consider your opinion to have merit.
Regards,
BK
I don't disagree completely, but why wouldn't Mc wait to get to $1 or above, organically? Then only RS at 10-1? I'd think that he would start higher than 30 million shares because of the unique business environment/situation. It only requires a little patience, and possibly only a few months, depending on what progress is made. I do understand that up-listing would be well supported if we up-list and then announce that we're ahead of the published milestones. I just don't think he would do 20-1 unless Wall Street is sooo.. anxious that they just can't wait to get a piece of this company. I'm in the camp of being hopeful for organic PPS increase to above a $1 first.
So, if we're analyzing what may transpire as news, that would hypothetically move the pps, here is what we have left to move the share price.
A) End effector partner
B) Design freeze
C) Milestone advancement - indication data completed ahead of schedule/no device refinement necessary to get the majority of surgical functions fully authenticated from all 3 (or more) sources.
D) Incremental partnership/JV.
E) Full partnership
F) FDA submission
G) Buy-out
H) Interest rates
How Mc is working toward critical mass. Why did Mac issue raises with warrants? Because IMO, cash is the fuel that creates the ability to move C forward sooner and give Titan the value of time. The timeline has always been the most valuable element between now and buyout.
I think that C creates "the domino effect." It forces companies to contact Titan sooner, or risk being left without an opportunity to participate in robotic surgery for many years. Again time becomes the most valuable element not only for Titan, but for those companies that are currently active in the surgical business environment. Something else to consider - what about large conglomerates that see the medical device business as the growth segment that which they will invest their capital. Canon has been doing this quietly for more than 10 years. Samsung sold their copier division to HP last year and has +$1B to further diversify their business model. Think of all the companies in countries that MUST have businesses that will generate revenue as part of their export economy. They don't have the resources from which to create IP/products. They MUST buy them. You can name another dozen or more large corporations that are flush with cash, and looking for a place to park it.
Now D and E are likely sooner than later, for 2 reasons. First to prevent G from occurring, and 2 - if the up-list is overwhelming, then the market capitalization will become so high that Titan may become too big to swallow. And..... interest rates must continue to be very low. There's the possibility that the acquiring company may need to issue debt to win the bidding war. So time is very important.
G is what it is. Another company just gets anxious anddecides to move quickly, before another competitor emerges. H also contributes to G.
It will be interesting to hear what everyone else thinks.
Regards,
BK
Thanks Scalpel. Good to be back. Lets see what the next few weeks bring.
Regards,
BK
Hello to all. Happy Thanksgiving. El Guapo, I agree 100% with what you are posing. I think they're done with the "add-this, add-that" because it almost cost them the ability to build the prototype devices, and it did cost the former CEO his job. But I have 3 theories as to why Mc has done what we've seen so far.
A) He raised the most current offering because the "street" did want to participate any way that they could, and it was to Titan's benefit. There is/was some anxiety expressed with the issuance of a full warrant, etc., etc., and the "why did they do that?" if the most recent private placement didn't include that form of additional dilution.
B) My only conclusion for the additional unnecessary warrants was to initiate a quid-pro-quo, with the street, based on the possible R/S and the support required. Even if someone would make the argument that surgeons would be happy to finance the balance of the financing. Wall Street wants their piece of the pie and wants to be in the drivers seat. I don't think it's making a deal with the devil, if it's overwhelming PPS support. Both the surgeons and private equity firms can participate.
C) And most importantly - Money, and support permit the option to advance the timeline. The most recent comments regarding a "tweak" from the Columbia site, doesn't necessarily mean that it needs to be included in the 1.0 version. 90% out of 100% is still an A grade. I also base this theory on the comments someone made that Titan feels that they can sell 12 units without a salesforce. I'd go further with that statement that once this model is FDA approved, they could take advanced PO's for at least 50 units. The question is how long would it take for them to build and deliver them? 1.0 doesn't have to have the full functionality for a long list if indications, just the most important 4 - 6. If Titan only thinks that they will sell 12 units, how much functionality is necessary? I thought that the device was being approved on the basis of basic surgical functions (cut, cautery, suture, etc.) .
My final question is - what is the end goal here? Create and run an industry changing, highly-advanced surgical device company, or make a ##@&%! load of money? The ideal answer would be both. Perhaps a partner would buyout Titan and make the entire operation a division to facilitate version 1.2, 1.3 and 2.0. The existing software and hardware engineers would have a huge learning curve advantage. The patents and the time to R&D, test and build, and learn are reason to buy Titan. Experience is expensive and painful. The patents and learning curve necessary to create a fully functional device is more than daunting.
Finally, who cares about whipples, I want to see some video games on the monitor, using both controllers. Just to calibrate the movement, and give the eyeballs a break.
Just food for thought. I guess we'll see if I'm full of beans? Pun intended.
Regards,
BK
Yes. Yes it was. Hello - been reading. Have new job. Didn't see reason to continue to post same relivent comments. I still hold strongly to those statements and only time will tell. If they're not building those new units, it may be b/c someone said , it's not necessary b/c this version works. Plain & simple. Work the nhancments into 2.0. All the R/S did was to make me nervous. If it's delayed, that's a very good thing. And I do think there's a lot going on in the background. Mc didn't bring on the VP Eng to delay the launch. He's here to shorten up & tighten (pun intended) up this timeline. They needed to know how this works compared to the predicate device. Who better to tell them than the surgeon with the most experience?
Regards,
BK
I'm thinking Dr. Patel was/is the key.
He's invited to compare and contrast SPORTS capabilities. IMO
He says, it will do this, this and this. Great.
No red flags. Design and eval unit confirmed and complete.
Software always takes longer than expected.
Which is why they needed to reel in those (speculated) design enhancements.
I've always asked, "Why can't some or most be moved to SPORT 2.0?"
I think Mc concurs.
The IP checks out - except one. Not as good as I'd hoped.
We'll see how this shakes out the rest of this spring and over the summer.
If SPORT is demo'd, we may get a surprise. IDK.
I'm looking at the tech, and capability and see other applications.
Just get this first one done.
JMO
Regards,
BK
I'm not so sure about that thought.
The only time a "better mouse trap" design/product doesn't work:
When the old one still does the job - ok, they win
When the old one is less expensive - ok, we win
When the new can be used without any environmental modifications - ok, we win
When the new one is more complicated - ok, we win
Further, the price announcement is strategic. As soon as ISRG starts to feel the pinch and loses business, they WILL lower pricing. Now we have room to lower it too, and still be profitable.
Please keep in mind, we do compete on differing features. It's a completely mobile device. This is VERY important because most existing facilities, especially at the US Dept of Veterans Affairs, were designed without floor space/footprint for copiers, let alone large surgical robots. The rooms were just not designed with any expansion in mind. FYI - the VA has +160 large hospital facilities.
SPORT is flexible as to the number of procedures that it can perform. If I were CEO, I'd compete, until ISRG does something drastic, at the same or very close to the same pricing. The SPORT system should have been designed for modular sub-assembly replacement (hot-swap), and remote-secure diagnostics, and firmware upgrades. All less costly than a 10-15 year design.
JMO
Regards,
BK
I'm drawing a conclusion from one of the first videos showing precision and functionality.
I'll admit, it wasn't stitching per-se.
It was passing surgical thread through eye of a needle and tying a knot.
I may be wrong.. and I expect a reply from this board, but my conclusion is that if the arms can work simultaneously, and in a coordinated manner, showing this functionality, it can stitch.
Ok, everyone weigh in.k
Thanks.
BK
Just catching up.
Didn't we see stitching during the partial nephrectomy video shown at the AGM 2015?
I know the video is on the website too.
I may not be remembering the dates correctly.
IMO.
Regards,
BK
Thou protest too much....methinks.
I expect you to argue, because that's seems to be your new recreational activity, as of late.
I'm directing these questions regarding your efforts and participation on this board, and question your motivation as such.
Yes, they needed to hire a Director for the lab. How can you not see that this is necessary if the lab is to open as scheduled?
You're giving off the impression that you're trying to suppress the pps with negative comments about every single move, and announcement.
JMO
Regards,
BK